Capital Research Global Investors Has $167.62 Million Stock Position in Houlihan Lokey, Inc. $HLI

Capital Research Global Investors lifted its position in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 0.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 962,263 shares of the financial services provider’s stock after buying an additional 5,822 shares during the quarter. Capital Research Global Investors’ holdings in Houlihan Lokey were worth $167,617,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Royal Bank of Canada increased its position in shares of Houlihan Lokey by 14.4% in the first quarter. Royal Bank of Canada now owns 49,584 shares of the financial services provider’s stock worth $8,008,000 after purchasing an additional 6,253 shares during the period. AQR Capital Management LLC increased its position in shares of Houlihan Lokey by 50.0% in the first quarter. AQR Capital Management LLC now owns 29,654 shares of the financial services provider’s stock worth $4,598,000 after purchasing an additional 9,891 shares during the period. Millennium Management LLC bought a new position in shares of Houlihan Lokey in the first quarter worth $18,964,000. Goldman Sachs Group Inc. increased its position in shares of Houlihan Lokey by 5.7% in the first quarter. Goldman Sachs Group Inc. now owns 415,743 shares of the financial services provider’s stock worth $67,143,000 after purchasing an additional 22,553 shares during the period. Finally, Arrowstreet Capital Limited Partnership bought a new position in shares of Houlihan Lokey in the second quarter worth $1,033,000. Institutional investors and hedge funds own 78.07% of the company’s stock.

Insider Transactions at Houlihan Lokey

In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 500 shares of Houlihan Lokey stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $143.40, for a total value of $71,700.00. Following the transaction, the general counsel owned 500 shares in the company, valued at $71,700. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Scott L. Beiser sold 6,265 shares of Houlihan Lokey stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $150.26, for a total value of $941,378.90. Following the completion of the transaction, the chairman owned 6,265 shares in the company, valued at approximately $941,378.90. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 22.83% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on HLI shares. The Goldman Sachs Group decreased their price target on Houlihan Lokey from $210.00 to $184.00 and set a “buy” rating on the stock in a research report on Wednesday, April 1st. Weiss Ratings cut Houlihan Lokey from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday, April 21st. Morgan Stanley decreased their price target on Houlihan Lokey from $205.00 to $193.00 and set an “overweight” rating on the stock in a research report on Thursday, April 9th. UBS Group set a $160.00 price target on Houlihan Lokey in a research report on Thursday, May 7th. Finally, Keefe, Bruyette & Woods decreased their price target on Houlihan Lokey from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Five equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $191.29.

Houlihan Lokey Stock Down 1.7%

Houlihan Lokey stock opened at $136.86 on Tuesday. Houlihan Lokey, Inc. has a 12-month low of $134.41 and a 12-month high of $211.78. The business’s 50-day moving average price is $149.66 and its two-hundred day moving average price is $162.62. The stock has a market cap of $9.45 billion, a PE ratio of 22.00, a P/E/G ratio of 1.08 and a beta of 0.95.

Houlihan Lokey (NYSE:HLI) last released its earnings results on Wednesday, May 6th. The financial services provider reported $1.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.79 by ($0.16). Houlihan Lokey had a net margin of 16.26% and a return on equity of 22.88%. The business had revenue of $635.64 million during the quarter, compared to the consensus estimate of $679.22 million. During the same quarter in the prior year, the firm earned $1.96 EPS. The business’s revenue was down 4.6% on a year-over-year basis. As a group, analysts expect that Houlihan Lokey, Inc. will post 8.54 earnings per share for the current year.

Houlihan Lokey Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.70 dividend. This is a boost from Houlihan Lokey’s previous quarterly dividend of $0.60. This represents a $2.80 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Monday, June 1st. Houlihan Lokey’s dividend payout ratio (DPR) is presently 45.02%.

Houlihan Lokey Profile

Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.

The firm’s core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.